Australian Gonococcal Surveillance Programme, 1 January to 31 March 2021

Authors

  • Monica M Lahra World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, New South Wales Health Pathology, Microbiology, The Prince of Wales Hospital, Randwick, NSW, 2031
  • Masoud Shoushtari World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, New South Wales Health Pathology, Microbiology, The Prince of Wales Hospital, Randwick, NSW, 2031
  • Tiffany R Hogan World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, New South Wales Health Pathology, Microbiology, The Prince of Wales Hospital, Randwick, NSW, 2031

DOI:

https://doi.org/10.33321/cdi.2021.45.47

Keywords:

antimicrobial resistance, disease surveillance, gonococcal infection, Neisseria gonorrhoeae

Abstract

The Australian National Neisseria Network (NNN) comprises reference laboratories in each state and territory that report data on antimicrobial susceptibility testing to an agreed group of antimicrobial agents for the Australian Gonococcal Surveillance Programme (AGSP). This report presents national gonococcal antimicrobial resistance surveillance data for the indicated quarter.

Downloads

Download data is not yet available.

References

Lahra MM, Shoushtari M, George CRR, Armstrong BH, Hogan TR. Australian Gonococcal Surveillance Programme Annual Report 2019. Commun Dis Intell (2018). 2020;44. doi: https://doi.org/10.33321/cdi.2020.44.58.

Unemo M. Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis. 2015;15:364.

Downloads

Published

30/08/21

How to Cite

Lahra, Monica M, Masoud Shoushtari, and Tiffany R Hogan. 2021. “Australian Gonococcal Surveillance Programme, 1 January to 31 March 2021 ”. Communicable Diseases Intelligence 45 (August). https://doi.org/10.33321/cdi.2021.45.47.

Issue

Vol. 45 (2021)

Section

Quarterly report

Categories

License

Copyright (c) 2021 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 7 8 9 10 > >>